SironRX Therapeutics
SironRX Therapeutics: Innovating regenerative therapies for wound repair and scar prevention in the US.
Founded
2010SironRX Therapeutics: Innovating regenerative therapies for wound repair and scar prevention in the US.
SironRX Therapeutics, founded with a mission to innovate in the field of regenerative medicine, focuses on developing novel therapies that leverage the body's natural cell responses to tissue injury. The company's core vision is to enhance wound repair and prevent scarring of dermal wounds through advanced regenerative treatments. SironRX Therapeutics operates primarily within the United States, providing cutting-edge solutions aimed at improving patient outcomes in wound care.
Notable figures affiliated with SironRX Therapeutics include leading scientists and medical professionals specializing in regenerative medicine. The company has attracted significant interest from investors focused on healthcare innovation. Key achievements include successful preclinical trials demonstrating the efficacy of their therapies in promoting wound healing and reducing scar formation. SironRX Therapeutics continues to make a substantial impact in the regenerative medicine market, driving advancements that promise to transform wound care practices.
Companies similar to SironRX Therapeutics include RegeneRx Biopharmaceuticals, CarthroniX, InGeneron and Juventas Therapeutics.
SironRX Therapeutics was founded in 2010.
SironRX Therapeutics' headquarters is located in Cleveland, OH, US.
SironRX Therapeutics' most recent funding round was for $3.4M (USD) in August 2011.
As of Aug 16, 2011, SironRX Therapeutics has raised a total of $3.9M (USD).
SironRX Therapeutics has 6 employees as of Feb 5, 2024.
InGeneron
ingeneron.com
